HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Factor VIIa analog has marked effects on platelet function and clot kinetics in blood from patients with hemophilia A.

Abstract
To evaluate the hemostatic effects of NN1731 and rFVIIa, an ex-vivo study in hemophilia patients used the Hemodyne Hemostasis Analysis System (HAS) to measure platelet contractile force (PCF), clot elastic modulus (CEM), and force onset time (FOT), and the Haemoscope Thrombelastograph (TEG) to measure reaction time (R), kinetics time (K), and maximum amplitude (MA). Blood samples from 10 healthy volunteers and 10 Factor VIII-deficient patients of varying severity (mild, moderate, severe), were spiked with rFVIIa and NN1731 (both 0.64 and 1.28 microg/ml, respectively) and analyzed to characterize platelet function and clot kinetics. There was wide variability in the rFVIIa response. NN1731 had greater and more consistent effects on PCF, CEM, FOT, R, and K relative to rFVIIa, in all hemophilia groups. The lowest NN1731 concentration (0.64 microg/ml) shortened R and FOT, and increased CEM and PCF more than rFVIIa 1.28 microg/ml. NN1731 normalized clotting parameters equivalent to values obtained in healthy volunteers. FOT and R were highly correlated (r = 0.96). No correlation was observed between CEM and MA. NN1731 produced less variable, more pronounced and predictable ex-vivo hemostatic effects on PCF, CEM, FOT, R and K than rFVIIa in all hemophilia groups. HAS and TEG assays provided similar estimates of FOT and R, however CEM appeared to be more sensitive than MA to changes in clot firmness.
AuthorsDonald F Brophy, Erika J Martin, Melinda E Nolte, Janice G Kuhn, J Christian Barrett, Mirella Ezban
JournalBlood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis (Blood Coagul Fibrinolysis) Vol. 21 Issue 6 Pg. 539-46 (Sep 2010) ISSN: 1473-5733 [Electronic] England
PMID20581663 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • NN1731
  • Recombinant Proteins
  • Factor VII
  • recombinant FVIIa
  • Factor VIIa
Topics
  • Adult
  • Aged
  • Blood Coagulation (drug effects)
  • Blood Platelets (drug effects, physiology)
  • Case-Control Studies
  • Clot Retraction (drug effects)
  • Factor VII (pharmacology)
  • Factor VIIa (pharmacology)
  • Hemophilia A (blood, drug therapy)
  • Hemostasis (drug effects)
  • Humans
  • Kinetics
  • Middle Aged
  • Recombinant Proteins (pharmacology)
  • Thrombelastography
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: